Collectively, these results suggest that p53 TAD PEP functions as a peptide inhibitor that targets the FOXO4-p53 interaction
Currently available circuit therapeutics (STN-, GPi-, VIM-DBS and VIM-MRgFUS) all target regions within this SCAN circuit and modulate the cortical SCAN regions, as evidenced by our DBS-ECoG (Fig
The MIC compounds complement these effects by promoting efficient fat metabolism and supporting liver health
L., Montesi, L., Colosimo, S., Caletti, M
FIGURE 3 3.1 The effect of uremic toxins The progression of CKD is accompanied by the accumulation of diverse uremic toxins, which significantly accelerates the process of eryptosis
An important role for glutathione and -glutamyltranspeptidase in the supply of growth requirements during nitrogen starvation of the yeast Saccharomyces cerevisiae